ArticleACS chemical biology2020

Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm.

Matthias R Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.